• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

氨基葡萄糖干扰骨髓生成并增强髓源性抑制细胞的免疫抑制活性。

Glucosamine Interferes With Myelopoiesis and Enhances the Immunosuppressive Activity of Myeloid-Derived Suppressor Cells.

作者信息

Lin Eric Chang-Yi, Chen Shuoh-Wen, Chen Luen-Kui, Lin Ting-An, Wu Yu-Xuan, Juan Chi-Chang, Chang Yuan-I

机构信息

Department and Institute of Physiology, College of Medicine, National Yang Ming Chiao Tung University, Taipei City, Taiwan.

Department of Internal Medicine, School of Medicine, College of Medicine, National Yang Ming Chiao Tung University, Taipei City, Taiwan.

出版信息

Front Nutr. 2021 Nov 10;8:762363. doi: 10.3389/fnut.2021.762363. eCollection 2021.

DOI:10.3389/fnut.2021.762363
PMID:34901113
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8660085/
Abstract

Glucosamine (GlcN) is the most widely consumed dietary supplement and exhibits anti-inflammatory effects. However, the influence of GlcN on immune cell generation and function is largely unclear. In this study, GlcN was delivered into mice to examine its biological function in hematopoiesis. We found that GlcN promoted the production of immature myeloid cells, known as myeloid-derived suppressor cells (MDSCs), both and . Additionally, GlcN upregulated the expression of glucose transporter 1 in hematopoietic stem and progenitor cells (HSPCs), influenced HSPC functions, and downregulated key genes involved in myelopoiesis. Furthermore, GlcN increased the expression of arginase 1 and inducible nitric oxide synthase to produce high levels of reactive oxygen species, which was regulated by the STAT3 and ERK1/2 pathways, to increase the immunosuppressive ability of MDSCs. We revealed a novel role for GlcN in myelopoiesis and MDSC activity involving a potential link between GlcN and immune system, as well as the new therapeutic benefit.

摘要

氨基葡萄糖(GlcN)是消费最为广泛的膳食补充剂,具有抗炎作用。然而,GlcN对免疫细胞生成和功能的影响在很大程度上尚不清楚。在本研究中,将GlcN导入小鼠体内以检测其在造血过程中的生物学功能。我们发现,GlcN促进了未成熟髓样细胞的产生,即髓样来源的抑制细胞(MDSCs),无论是在体内还是体外。此外,GlcN上调了造血干细胞和祖细胞(HSPCs)中葡萄糖转运蛋白1的表达,影响了HSPCs的功能,并下调了参与髓系造血的关键基因。此外,GlcN增加了精氨酸酶1和诱导型一氧化氮合酶的表达,以产生高水平的活性氧,这由STAT3和ERK1/2信号通路调控,从而增强了MDSCs的免疫抑制能力。我们揭示了GlcN在髓系造血和MDSC活性中的新作用,涉及GlcN与免疫系统之间的潜在联系以及新的治疗益处。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/348b/8660085/83c65b3c3469/fnut-08-762363-g0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/348b/8660085/a3a8f37008c5/fnut-08-762363-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/348b/8660085/b01f417675de/fnut-08-762363-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/348b/8660085/d822c65024fe/fnut-08-762363-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/348b/8660085/648c6a60cbe4/fnut-08-762363-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/348b/8660085/83c65b3c3469/fnut-08-762363-g0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/348b/8660085/a3a8f37008c5/fnut-08-762363-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/348b/8660085/b01f417675de/fnut-08-762363-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/348b/8660085/d822c65024fe/fnut-08-762363-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/348b/8660085/648c6a60cbe4/fnut-08-762363-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/348b/8660085/83c65b3c3469/fnut-08-762363-g0006.jpg

相似文献

1
Glucosamine Interferes With Myelopoiesis and Enhances the Immunosuppressive Activity of Myeloid-Derived Suppressor Cells.氨基葡萄糖干扰骨髓生成并增强髓源性抑制细胞的免疫抑制活性。
Front Nutr. 2021 Nov 10;8:762363. doi: 10.3389/fnut.2021.762363. eCollection 2021.
2
Myeloid-Derived Suppressor Cells in Infection.中性粒细胞来源的抑制细胞在 感染中的作用。
Front Cell Infect Microbiol. 2021 Aug 27;11:737364. doi: 10.3389/fcimb.2021.737364. eCollection 2021.
3
Interferon regulatory factor 4 (IRF4) controls myeloid-derived suppressor cell (MDSC) differentiation and function.干扰素调节因子 4(IRF4)控制髓系来源的抑制细胞(MDSC)分化和功能。
J Leukoc Biol. 2016 Dec;100(6):1273-1284. doi: 10.1189/jlb.1A0215-068RR. Epub 2016 Sep 6.
4
HCV-Associated Exosomes Upregulate RUNXOR and RUNX1 Expressions to Promote MDSC Expansion and Suppressive Functions through STAT3-miR124 Axis.HCV 相关外泌体通过 STAT3-miR124 轴上调 RUNXOR 和 RUNX1 的表达,促进 MDSC 扩增和抑制功能。
Cells. 2020 Dec 18;9(12):2715. doi: 10.3390/cells9122715.
5
Myeloid derived suppressor cells-An overview of combat strategies to increase immunotherapy efficacy.髓源性抑制细胞——提高免疫治疗疗效的战斗策略概述。
Oncoimmunology. 2015 Feb 3;4(1):e954829. doi: 10.4161/21624011.2014.954829. eCollection 2015 Jan.
6
IL-18 enhances immunosuppressive responses by promoting differentiation into monocytic myeloid-derived suppressor cells.白细胞介素-18通过促进分化为单核细胞来源的髓系抑制细胞来增强免疫抑制反应。
J Immunol. 2014 Dec 1;193(11):5453-60. doi: 10.4049/jimmunol.1401282. Epub 2014 Oct 31.
7
Detection of a TLR2 agonist by hematopoietic stem and progenitor cells impacts the function of the macrophages they produce.造血干细胞和祖细胞对 TLR2 激动剂的检测影响其产生的巨噬细胞的功能。
Eur J Immunol. 2013 Aug;43(8):2114-25. doi: 10.1002/eji.201343403. Epub 2013 Jun 7.
8
Myeloid-specific expression of human lysosomal acid lipase corrects malformation and malfunction of myeloid-derived suppressor cells in lal-/- mice.人溶酶体酸性脂肪酶在髓系细胞中的特异性表达纠正了 lal-/- 小鼠中髓源性抑制细胞的畸形和功能障碍。
J Immunol. 2011 Oct 1;187(7):3854-66. doi: 10.4049/jimmunol.1003358. Epub 2011 Sep 7.
9
The Granulocyte Progenitor Stage Is a Key Target of IRF8-Mediated Regulation of Myeloid-Derived Suppressor Cell Production.粒细胞祖细胞阶段是IRF8介导的髓源性抑制细胞产生调控的关键靶点。
J Immunol. 2017 May 15;198(10):4129-4139. doi: 10.4049/jimmunol.1601722. Epub 2017 Mar 29.
10
The mTOR signal regulates myeloid-derived suppressor cells differentiation and immunosuppressive function in acute kidney injury.mTOR信号调节急性肾损伤中髓源性抑制细胞的分化和免疫抑制功能。
Cell Death Dis. 2017 Mar 23;8(3):e2695. doi: 10.1038/cddis.2017.86.

引用本文的文献

1
Pharmacological modulation of myeloid-derived suppressor cells to dampen inflammation.药物调节髓源性抑制细胞以抑制炎症。
Front Immunol. 2022 Aug 30;13:933847. doi: 10.3389/fimmu.2022.933847. eCollection 2022.

本文引用的文献

1
IL-6 Promotes the Proliferation and Immunosuppressive Function of Myeloid-Derived Suppressor Cells via the MAPK Signaling Pathway in Bladder Cancer.IL-6 通过 MAPK 信号通路促进膀胱癌中髓源性抑制细胞的增殖和免疫抑制功能。
Biomed Res Int. 2021 Apr 23;2021:5535578. doi: 10.1155/2021/5535578. eCollection 2021.
2
Myeloid-derived suppressor cells as cellular immunotherapy in transplantation and autoimmune diseases.髓源性抑制细胞作为细胞免疫疗法在移植和自身免疫性疾病中的应用。
Cell Immunol. 2021 Apr;362:104300. doi: 10.1016/j.cellimm.2021.104300. Epub 2021 Feb 4.
3
Myeloid-derived suppressor cells in the era of increasing myeloid cell diversity.
在髓系细胞多样性不断增加的时代中的髓源性抑制细胞。
Nat Rev Immunol. 2021 Aug;21(8):485-498. doi: 10.1038/s41577-020-00490-y. Epub 2021 Feb 1.
4
Differential expansion of circulating human MDSC subsets in patients with cancer, infection and inflammation.循环中人类 MDSC 亚群在癌症、感染和炎症患者中的差异扩张。
J Immunother Cancer. 2020 Sep;8(2). doi: 10.1136/jitc-2020-001223.
5
Glucosamine regulation of fibroblast growth factor 21 expression in liver and adipose tissues.葡萄糖胺对肝和脂肪组织中成纤维细胞生长因子 21 表达的调节作用。
Biochem Biophys Res Commun. 2020 Aug 27;529(3):714-719. doi: 10.1016/j.bbrc.2020.06.070. Epub 2020 Jul 18.
6
Myeloid-Derived Suppressor Cells in the Context of Allogeneic Hematopoietic Stem Cell Transplantation.异基因造血干细胞移植背景下的髓源性抑制细胞。
Front Immunol. 2020 May 22;11:989. doi: 10.3389/fimmu.2020.00989. eCollection 2020.
7
Expansion of myeloid-derived suppressor cells in patients with severe coronavirus disease (COVID-19).骨髓来源的抑制性细胞在重症冠状病毒病(COVID-19)患者中的扩增。
Cell Death Differ. 2020 Nov;27(11):3196-3207. doi: 10.1038/s41418-020-0572-6. Epub 2020 Jun 8.
8
The extracellular signal-regulated kinase 1/2 modulates the intracellular localization of DNA methyltransferase 3A to regulate erythrocytic differentiation.细胞外信号调节激酶1/2调节DNA甲基转移酶3A的细胞内定位以调控红细胞分化。
Am J Transl Res. 2020 Mar 15;12(3):1016-1030. eCollection 2020.
9
The Emerging Landscape of Immune Cell Therapies.免疫细胞疗法的新兴领域。
Cell. 2020 Apr 2;181(1):46-62. doi: 10.1016/j.cell.2020.03.001.
10
Myeloid-Derived Suppressor Cells as a Therapeutic Target for Cancer.髓源性抑制细胞作为癌症治疗靶点。
Cells. 2020 Feb 27;9(3):561. doi: 10.3390/cells9030561.